Mode
Text Size
Log in / Sign up
N/A N=26 Randomized Treatment

Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management

Esophageal Dilation · Refractory Benign Esophageal Stricture

Enrolled (actual)
26
Serious AEs
3.2%
Results posted
May 2023
Primary outcome: Primary: Number of Endoscopic Interventions — 12; 11; 12; 7 endoscopies

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Esophageal self-dilation therapy (Device); Endoscopic therapy with esophageal dilation (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Mayo Clinic
Primary completion
Jul 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Endoscopic Interventions
12; 11; 12; 7
SECONDARY
Length of Days Intervention Free
7; 82; 147
SECONDARY
Mayo Dysphagia Questionnaire (MDQ-30) at Baseline
7.16; 7.56; 5.36
SECONDARY
Mayo Dysphagia Questionnaire (MDQ-30) at 12 Months
5.55; 5.83; 5.17
SECONDARY
Clinically Significant Adverse Events
0; 0; 0; 1

Summary

This study is being done to see which treatment is more effective in improving the difficulty of swallowing. Researchers are comparing self-dilation to endoscopic dilation.

Eligibility Criteria

Inclusion Criteria

  • Refractory benign esophageal stricture defined as an esophageal stricture with persistent dysphagia despite undergoing 5 endoscopic dilations within a 1 year period. Persistent dysphagia will be considered if patients has solid food dysphagia at least once a week

Exclusion Criteria

  • Patient with malignant esophageal stricture
  • Angulated stricture which prevents safe passage of Maloney dilator in office setting
  • In ability to achieve an esophageal diameter of 10 mm with endoscopic dilation
  • Known significant esophageal motor disorder (i.e. achalasia, aperistalsis, functional obstruction, jackhammer, distal esophageal spasm)*
  • The presence of esophageal stent
  • Inability to learn self-dilation secondary to blindness or cognitive dysfunction
  • Use of chronic anticoagulants
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03738566). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search